NEW YORK, March 16 (GenomeWeb News) - Shares of CombiMatrix were up 12.4 percent, or $.24, at $2.18 in afternoon trading after parent Acacia announced that the European patent office had granted CombiMatrix a patent titled "self-assembling arrays" (EP1185363B1).


To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.